These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 28035589)

  • 1. Caspofungin Population Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-Venous Haemofiltration or Haemodiafiltration.
    Roger C; Wallis SC; Muller L; Saissi G; Lipman J; Brüggemann RJ; Lefrant JY; Roberts JA
    Clin Pharmacokinet; 2017 Sep; 56(9):1057-1068. PubMed ID: 28035589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Renal Replacement Modalities on Amikacin Population Pharmacokinetics in Critically Ill Patients on Continuous Renal Replacement Therapy.
    Roger C; Wallis SC; Muller L; Saissi G; Lipman J; Lefrant JY; Roberts JA
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4901-9. PubMed ID: 27270279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients.
    Roger C; Wallis SC; Louart B; Lefrant JY; Lipman J; Muller L; Roberts JA
    J Antimicrob Chemother; 2016 Jun; 71(6):1643-50. PubMed ID: 26957490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of linezolid in critically ill patients on renal replacement therapy: comparison of equal doses in continuous venovenous haemofiltration and continuous venovenous haemodiafiltration.
    Roger C; Muller L; Wallis SC; Louart B; Saissi G; Lipman J; Lefrant JY; Roberts JA
    J Antimicrob Chemother; 2016 Feb; 71(2):464-70. PubMed ID: 26538503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosing of caspofungin based on a pharmacokinetic/pharmacodynamic index for the treatment of invasive fungal infections in critically ill patients on continuous venovenous haemodiafiltration.
    Pérez-Pitarch A; Ferriols-Lisart R; Aguilar G; Ezquer-Garín C; Belda FJ; Guglieri-López B
    Int J Antimicrob Agents; 2018 Jan; 51(1):115-121. PubMed ID: 28666752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micafungin pharmacokinetic/pharmacodynamic adequacy for the treatment of invasive candidiasis in critically ill patients on continuous venovenous haemofiltration.
    Maseda E; Grau S; Villagran MJ; Hernandez-Gancedo C; Lopez-Tofiño A; Roberts JA; Aguilar L; Luque S; Sevillano D; Gimenez MJ; Gilsanz F
    J Antimicrob Chemother; 2014 Jun; 69(6):1624-32. PubMed ID: 24505092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients.
    Maseda E; Grau S; Luque S; Castillo-Mafla MP; Suárez-de-la-Rica A; Montero-Feijoo A; Salgado P; Gimenez MJ; García-Bernedo CA; Gilsanz F; Roberts JA
    Crit Care; 2018 Apr; 22(1):94. PubMed ID: 29655372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of caspofungin in critically ill patients on continuous renal replacement therapy.
    Weiler S; Seger C; Pfisterer H; Stienecke E; Stippler F; Welte R; Joannidis M; Griesmacher A; Bellmann R
    Antimicrob Agents Chemother; 2013 Aug; 57(8):4053-7. PubMed ID: 23733471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Caspofungin Exposure in Patients in Intensive Care Units.
    van der Elst KC; Veringa A; Zijlstra JG; Beishuizen A; Klont R; Brummelhuis-Visser P; Uges DR; Touw DJ; Kosterink JG; van der Werf TS; Alffenaar JC
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micafungin Plasma Levels Are Not Affected by Continuous Renal Replacement Therapy: Experience in Critically Ill Patients.
    Vossen MG; Knafl D; Haidinger M; Lemmerer R; Unger M; Pferschy S; Lamm W; Maier-Salamon A; Jäger W; Thalhammer F
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Loading Micafungin Dose in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration or Continuous Venovenous Hemodiafiltration: A Population Pharmacokinetic Analysis.
    Garbez N; Mbatchi LC; Maseda E; Luque S; Grau S; Wallis SC; Muller L; Lipman J; Roberts JA; Lefrant JY; Roger C
    Ther Drug Monit; 2021 Dec; 43(6):747-755. PubMed ID: 33560097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of renal replacement modalities on the clearance of piperacillin-tazobactam administered via continuous infusion in critically ill patients.
    Roger C; Cotta MO; Muller L; Wallis SC; Lipman J; Lefrant JY; Roberts JA
    Int J Antimicrob Agents; 2017 Aug; 50(2):227-231. PubMed ID: 28689876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study.
    Sinnollareddy MG; Roberts JA; Lipman J; Akova M; Bassetti M; De Waele JJ; Kaukonen KM; Koulenti D; Martin C; Montravers P; Rello J; Rhodes A; Starr T; Wallis SC; Dimopoulos G;
    Crit Care; 2015 Feb; 19(1):33. PubMed ID: 25888060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration.
    Roberts JA; Udy AA; Bulitta JB; Stuart J; Jarrett P; Starr T; Lassig-Smith M; Roberts NA; Dunlop R; Hayashi Y; Wallis SC; Lipman J
    J Antimicrob Chemother; 2014 Sep; 69(9):2508-16. PubMed ID: 24879665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose Reduction of Caspofungin in Intensive Care Unit Patients with Child Pugh B Will Result in Suboptimal Exposure.
    Martial LC; Brüggemann RJ; Schouten JA; van Leeuwen HJ; van Zanten AR; de Lange DW; Muilwijk EW; Verweij PE; Burger DM; Aarnoutse RE; Pickkers P; Dorlo TP
    Clin Pharmacokinet; 2016 Jun; 55(6):723-33. PubMed ID: 26649870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Echinocandins: searching for differences. The example of their use in patients requiring continuous renal replacement therapy].
    de la Llama-Celis N; Huarte-Lacunza R; Gómez-Baraza C; Cañamares-Orbis I; Sebastián-Aldeanueva M; Arrieta-Navarro R
    Rev Esp Quimioter; 2012 Dec; 25(4):240-4. PubMed ID: 23303253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study.
    Broeker A; Wicha SG; Dorn C; Kratzer A; Schleibinger M; Kees F; Heininger A; Kees MG; Häberle H
    Crit Care; 2018 Dec; 22(1):341. PubMed ID: 30558639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole.
    Muhl E; Martens T; Iven H; Rob P; Bruch HP
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):671-8. PubMed ID: 11214774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspofungin Weight-Based Dosing Supported by a Population Pharmacokinetic Model in Critically Ill Patients.
    Märtson AG; van der Elst KCM; Veringa A; Zijlstra JG; Beishuizen A; van der Werf TS; Kosterink JGW; Neely M; Alffenaar JW
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32660990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of ciprofloxacin pharmacokinetics in critically ill patients undergoing continuous veno-venous haemodiafiltration.
    Spooner AM; Deegan C; D'Arcy DM; Gowing CM; Donnelly MB; Corrigan OI
    BMC Clin Pharmacol; 2011 Aug; 11():11. PubMed ID: 21816053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.